Collectively, the data derived from sRNA sequencing, clinical validation, and integrative bioinformatics analyses consistently highlight miR-17-5p as a central regulatory miRNA in TB, with MAP3K2 identified as a potential downstream functional target. The gene discussed is MAP3K2; the disease is tuberculosis.